In more detail, depending on the type of endometrial cancer, particularly in type I endometrial cancer, the most frequent mutations associated with the PI3K pathway are phosphatase and tensin homolog (PTEN) loss (77%) and PIK3CA mutation (53%) [7]. Here, PTEN is linked to endometrial cancer.